www.biotransformationevent.com Open in urlscan Pro
78.137.168.141  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Biopharma & Life Sciences Connected Live
January 25th 2024
Radisson Blu Hotel & Spa, Cork




Register
Contact us

Navigation
 * Home
 * Agenda
 * Speakers
 * Associations
 * Exhibitors
 * Sponsors
 * Media
   * Partners
   * Video Gallery
   * Orca Scanner
 * Register
 * Accommodation

 * Home
 * Agenda
 * Speakers
 * Associations
 * Exhibitors
 * Sponsors
 * Media
   
   * Partners
   * Video Gallery
   * Orca Scanner
 * Register
 * Accommodation

BioPharma & Life Sciences Connected Live
January 25th 2024 | Radisson Blu Hotel & Spa, Cork
REGISTER

--------------------------------------------------------------------------------

Book your place at the Biopharma & Life Sciences Connected conference and
exhibition to hear from leading national and international experts in
pharmaceutical manufacturing. The biopharma sector in Ireland is experiencing
significant challenges around supply chain issues, digital transformation,
automation, carbon reduction and regulatory changes..

The central theme of this event is to hear directly from industry leaders and
stakeholders who are willing to share challenges and solutions in practice. That
means, the spotlight in presentations will be on case studies from
pharmaceutical companies - allowing you to benefit from the speakers' experience
in their everyday practice.

Over 75 leading speakers involved in the development & manufacturing of
biopharmaceutical & biotech products & technology will participate in a full
day's schedule of keynote talks & panels on the topics shaping the sector.

Why Attend

 * Listen to over 75 expert talks and panel debates on the latest industry
   issues facing the biopharma & life sciences sector.
 * Avail of the excellent networking opportunities with peers throughout the day
 * Network with over 70 exhibitors displaying the latest technology and research
 * Meet with government support agencies and associations
 * Join our Q&A with industry thought leaders

Key Topics Include

 * Research & Innovation
 * Automation
 * Vaccine Manufacturing
 * Process Optimization
 * Tech Transfer
 * Digitalization
 * IoT & Industry 4.0
 * Covid 19 – Impact to the market
 * Hybrid Systems – Single Use and/or Stainless Steel
 * Biosimilars – Best-Practice
 * Ultrafast Project Execution
 * Turnkey
 * HVAC & Cleanroom Engineering
 * Cell & Gene Therapy

Call for Speakers

To speak, sponsor and or exhibit at the event please email
info@biotransformationevent.com

SPEAKERS CONFIRMED

UNA FEENEY

GLOBAL OCCUPATIONAL HEALTH AND WELLBEING STRATEGIST - ELI LILLY

Speaker Bio



Una oversees the planning, development, implementation, and monitoring of the
Global Occupational Health framework at Eli Lilly. In her role she works across
different global facilities to monitor and track the specific occupational and
personal health opportunities and metrics unique to each country. She supports
OUS manufacturing sites and affiliates to deliver wellbeing programs that create
awareness, enhance motivation, and provide tools to employees that help them
adapt and maintain a well-rounded healthy lifestyle. Supports occupational
health operations in technical assistance with project development,
implementation of employee health service-related projects and tasks.
Una is the National chairperson for INMO OHN section and represents Ireland as a
Board member on the Federation of Occupational Health Nurses EU (FOHNEU).
Una is a guest lecturer on the MSc Occupational Health UCC.


DR. IAN JONES

FOUNDER & CEO - INNOGLOBAL

Speaker Bio



Dr Ian Jones is the Founder and CEO of InnoGlobal. He has worked for the past 25
years supporting high-tech manufacturing where he has become a global thought
leader on Industry 5.0 and the associated technologies and skills strategies to
drive the digital transformation of these key industries. Ian holds a PhD in
Process Analytical Technologies from Technological University Dublin and has
studied Strategy, Leadership and Innovation at the Harvard Business School,
Boston and Accelerated Growth Strategies at Judge Business School, Cambridge,
UK. Ian also sits as an Adjunct Professor within the Department of Chemical
Sciences, Faculty of Science and Engineering at the University of Limerick,
Ireland. Ian is driven by the mission to help people, governments and businesses
succeed in digital and green transformation.


SINEAD KEOGH

HEAD OF SECTORS AND DIRECTOR - BIOPHARMACHEM IRELAND

"BIOPHARMA SECTOR IN IRELAND: PRIORITIES, CHALLENGES AND OPPORTUNITIES."

Speaker Bio Synopsis



Sinead is the Director of the Ibec’s Medtech and Engineering Sectors , which
includes the Irish Medtech Association. A number of Government Funded Skills
Networks (Skillnets, Apprenticeships and Springboards) fall under her remit.
Sinead currently sits on a number of national and international boards including
the Advisory Industry Board for Enterprise Ireland funded BioInnovate Ireland
and the Governance Board for Science Foundation Ireland funded Irish Photonic
Integration Centre (IPIC). She is a member of the National Executive Committee
at Medtech Europe. Prior to Ibec Sinead held technical roles at 3Com
Technologies, and lectured part-time at DIT, Kevin St. She holds a Ph.D. in the
Physics of Molecular Materials/Nanotechnology and B.Sc. (Hons.) in Applied
Physics, DIT Kevin St.





The biopharmaceutical sector in Ireland has experienced significant growth in
recent years, establishing itself as a key player in the global
biopharmaceutical industry. With €100bn+ in annual exports, 84,000 people
directly and indirectly employed and a further 10,000 jobs to be created over
the next 5 years, recent Ibec research indicates that confidence remains high
within the established base here. The sector’s growth is driven by a highly
skilled workforce, a collaborative ecosystem, strategic location, and a
supportive government. To maintain its position, the sector must adapt to the
emerging landscape [technological, regulatory, trade..….] and address workforce
and infrastructure challenges. With increasing investment in R&D, capital
infrastructure, digitilisation and sustainability anticipated, we must ensure we
have the right talent mix, especially in a tight labour market, to sustain the
industry and facilitate its transition. This presentation will cover
BioPharmChem Ireland’s strategy 2027 as well as recent sentiment data,
priorities, challenges, and opportunities in 2024.


CONOR MCALONAN

MAINTENANCE PLANNER - MSD IRELAND

"BEING THE GATEKEEPER: THE NEW INDUSTRIAL AGE AND HOW TO KEEP PHARMACEUTICAL
SUPPLY CHAINS MOVING."

Speaker Bio



Conor McAlonan is an accomplished and dedicated professional with a diverse
background in the biopharmaceutical industry. Hailing from the vibrant city of
Philadelphia, Conor brings a unique perspective to the table as a US Army
Veteran, chef, and in biopharmaceuticals.

With over 20 years of experience as a chef, Conor understands the importance of
precision, attention to detail, and the necessity for seamless processes. This
culinary background sparked his interest in the operational aspects of the
industry, leading him to pursue a Bachelor's (Hons) degree in Global Supply
Chain Management from Munster Technological University.

Conor's journey in the pharmaceutical sector has been an impressive one. He has
worked across multiple domains, including Supplier Quality Management, Supply
Chain, and Warehousing, acquiring a holistic understanding of the intricacies
involved in delivering pharmaceuticals efficiently and effectively. Conor's
ability to streamline operations and optimize supply chains has been
instrumental in increasing productivity and reducing costs.

Currently, Conor serves as a Maintenance Engineer in the pharmaceutical sector,
where his vast knowledge in digital strategy and process improvement plays a
pivotal role in maximizing operational efficiency. His expertise and innovative
thinking have led to the successful implementation of many digital solutions in
various organizations, propelling them towards a more technologically advanced
and optimized future.

With a genuine passion for his field, Conor strives to inspire and empower
others to embrace digital strategies and process improvement techniques to
enhance their organizations' overall performance and contribute to the
advancement of the biopharmaceutical industry.


PAUL MCCABE

CHIEF OPERATING OFFICER - VLE THERAPEUTICS

JOHN MCKEON

FOUNDER & CEO - GALLARUS INDUSTRY SOLUTIONS

Speaker Bio



John McKeon is the founder and Chief Executive Officer of Gallarus Industry
Solutions limited. Leading the company in its vision and mission, to deliver
innovative services and solutions to our clients, supporting a seamless
transition in the complex evolution of Industry 4.0. In recent years, John’s
focus has been primarily on leading design changes and technological innovation
in the pharmaceutical sector. His mindset is very much tuned to solving a
business need with innovative and tailor-made solutions.

He has achieved over 25 years as an engineer in the international marketplace
bringing a unique blend of leadership spanning several major sectors in
engineering and technology. Among them; aviation (heavy air-frame maintenance),
semiconductor manufacturing , medical device manufacturing, large scale
pharmaceutical finishing plant infrastructure, production line equipment
engineering, and design.


MATT MORAN

CONSULTANT & FORMER DIRECTOR - BIOPHARMACHEM IRELAND

"SHAPING THE FUTURE: DYNAMIC TRENDS AND CHALLENGES IN IRELAND'S BIOPHARMA
MANUFACTURING SPHERE AND Q&A"

Synopsis



Matt will be moderating a panel on "Shaping the Future: Dynamic Trends and
Challenges in Ireland's Biopharma Manufacturing Sphere and Q&A" with panellists
Ian Jones, Founder & President, Innoglobal, Vikram Kunnath, Technology
Consulting Partner, EY, Paul McCabe, Chief Operating Officer, VLE Therapeutics &
John O’Brien, Head of Engineering, Biomarin


JOHN O'BRIEN

DIRECTOR OF ENGINEERING - BIOMARIN

Speaker Bio



John is a passionate leader with over 20 years of experience in engineering
within the pharmaceutical and biotechnology industries.
Director of Engineering at BioMarin, a global leader in developing and
commercializing innovative therapies for rare diseases. John leads a team of
engineers and technicians responsible for end-to-end support of manufacturing
and laboratory operations at the BioMarin Shanbally Ireland facility.
John joined BioMarin in 2011 when the Shanbally facility was purchased. He has
worked in various technical and leadership roles in Engineering. In 2019 he
moved to California to work at BioMarin's manufacturing campus in Novato
California heading up the Automation, Process Engineering and Capital Project
functions. I returned to Ireland in 2022 to take up the role of Director of
Engineering at the Shanbally facility.
Before joining BioMarin, he spent 7 years at Pfizer, working at two of their
facilities: Pfizer Shanbally Biotechnology and Pfizer Loughbeg API (Active
Pharmaceutical Ingredients).
He has a Bachelor of Science in Process Plant Technology and a Bachelor of
Engineering in Mechanical Engineering. He started his career as an apprentice
mechanical technician at Pfizer Loughbeg. Throughout Johns career, he has
remained an advocate of apprenticeship programs in the industry.


DR. CIARÁN SEOIGHE

DEPUTY DIRECTOR GENERAL - SFI

"THE CRITICAL ROLE OF RESEARCH IN BUILDING A SUSTAINABLE FUTURE"

Speaker Bio Synopsis



Dr Ciarán Seoighe joined SFI as Deputy Director General in January 2018. In his
role, Ciarán is responsible for Organisational Strategy, Corporate
Communications and SFI’s International team. In addition, he deputises for the
Director General, as required. Ciarán joined SFI after nearly two decades in
management consulting with Accenture. In his time with Accenture, in both
Ireland and South Africa, Ciarán has worked with some of the world’s largest and
most successful organisations. He holds a BA (Mod) in Natural Science and PhD in
Quantum Physics from TCD. Since joining SFI, Ciarán has led the development of
SFI’s new strategy and been a regular contributor to national strategies and
initiatives including the Disruptive Technologies Innovation Fund Advisory
Board, the Public Service Innovation Advisory Board and the Creating Our Future
public consultation initiative. He brings a wealth of experience across a
variety of sectors executing large-scale transformation, innovation, strategic
and change initiatives.





Research has a key role to play in creating a better future for all. As humanity
faces a collective climate crisis, research and the talent it develops are more
important than ever. It is essential that the research itself is carried out
sustainably and that the talent and knowledge move through our society and
economy. Our vision is for the Irish public and private sectors to be leaders in
sustainable and environmentally sound practices because they are
research-enabled in their decision-making.


PHILIP CONNOLLY

ASSOCIATE DIRECTOR - SUSTAINABLE FUTURES - KPMG IRELAND

"DECARBONISING HIGH TEMPERATURE HEAT WITH BIOMETHANE"

Speaker Bio Synopsis



Philip is an associate director in the KPMG Sustainable Futures team. Philip has
9 years experience in the Irish energy industry, working in large utility
companies and with the Department of Environment, Climate and Communications on
a wide variety of decarbonisation technologies such as biomethane, carbon
capture and storage, hydrogen, compressed natural gas and future fuels such as
ammonia and sustainable aviation fuel. Philip has a deep understanding of
Ireland’s current energy and climate plans and specialises in biomethane. Philip
has recently worked with DAFM on drafting Ireland’s National Biomethane
Strategy.





To meet decarbonisation goals by 2030, Pharma and high temperature heat users in
Ireland will have limited decarbonisation options. Biomethane offers a solution
to assist on the pathway to decarbonisation. Ireland has ambitions to produce up
to 5.7 TWh of biomethane by 2030. While demand is likely to outstrip supply, I
will discuss the importance of biomethane to the Pharma and Lifesciences
sectors.


MIKE DINGLE

SENIOR PRODUCT SPECIALIST - TSI INCORPORATED

"BIOFLUORESCENT PARTICLE COUNTING – A SOLUTION FOR MEETING ANNEX 1 VIABLE AIR
TESTING REQUIREMENTS"

Speaker Bio Synopsis



Mike Dingle is a Senior Product Specialist at TSI where he provides application
support for the BioTrak Real-Time Viable Particle Counter and other TSI products
used to test and monitor controlled environments. Prior to joining TSI, Mike
worked as a QC Microbiologist in the pharmaceutical and medical device
industries for over 20 years where he developed and managed environmental
monitoring programs for a wide variety of controlled environments.





Annex 1 of the European Good Manufacturing Practices is the most widely followed
guidance in the world for the monitoring of pharmaceutical cleanrooms. After
numerous drafts and pandemic related delays, an update was released in 2022. A
push for modernization is a theme throughout the document. This is viewed as a
way to not only avoid shortages through increased production, but to also
improve quality. Biofluorescent Particle Counters (BFPC) are a modern method for
viable air monitoring in Grade A environments that is fully automated and
provides results in real-time. Implementing their use in place of traditional
microbiological methods increases process understanding and eliminates
interventions that interrupt production and introduce risk.


GUGLIELMO IOZZIA

ASSOCIATE DIRECTOR – APPLIED MATHEMATICS AND MODELLING DATA SCIENCE – ML/AI -
MSD

"REASONS WHY YOU COULDN’T (OR SHOULDN'T?) USE GENERALIST LLMS IN THE PHARMA
SPACE"

Speaker Bio Synopsis



Guglielmo is a Biomedical Engineer with an extensive background in Software
Engineering and ML/AI applied to different contexts, such as Biotech
Manufacturing, Healthcare and DevOps, just to mention the latest, and a lifelong
learner. At MSD, as part of the Data Science and Applied Mathematics Team he is
currently busy unlocking business value in the lab and manufacturing through
ML/AI initiatives.

He is also an international speaker and author: currently he is writing his
second technical book for Manning Publications, where he is going to share his
field experience on implementing domain-specific Large Language Models that can
be also executed offline, on private data and on commodity hardware





Generalist Large Language Models (LLMs) are available as a service from multiple
providers (OpenAI, Microsoft, Google, etc.) and show emergent capabilities that
can address diverse and more or less complex tasks. But they come also with
challenges and risks, in particular when they have to deal with domain-specific
and regulated industries, such as any in Life Sciences. This talk explores the
risks associated with generalist and closed source LLMs and showcases which
alternatives exist for domain-specific tasks in Pharma, to mitigate risks and
reduce the financial impact for adoption


DAVID KENIRY

CONSULTANT - KENIRY ADVISORY SERVICES

Speaker Bio



David advises on opportunities in the delivery and management of infrastructure,
energy, and housing projects. Based in Cork, David is also a consultant to the
Association for the Improvement of American Infrastructure (AIAI), an industry
body which serves as a resource for public and private sector leaders as they
consider public-private partnerships as an alternative solution to address
infrastructure.


TONY CLARKE

SVP OF IT DIGITAL OPERATIONS - ICON CLINICAL RESEARCH

"GENAI USE WITHIN BIOPHARMA AND LIFE SCIENCES INDUSTRIES"

Speaker Bio Synopsis



Tony is SVP of IT Digital Operations at ICON Clinical Research who provide
clinical trial solutions and employ 43,000 staff in 46 countries. Prior to
joining ICON he was VP of IT operations at Marken who are part of the UPS
family. Tony started his career in electronics and transitioned into Information
Technology where he began to focus in cybersecurity. Tony worked in consultancy
for several years providing IT services and building environments for banking,
telecoms, government, UN and EU agencies. Over the last 20 years, Tony has
provided IT & security services to several organisations across a wide variety
of industries before specialising in healthcare. His previous role was CISO with
ICON Clinical Research where he led a global security team and won several
Cybersecurity awards.



He is a strong believer in contributing to the information security community
and is currently co-chair of the Health-ISAC European Council and sits on the
Health-ISAC Global Threat Intelligence Committee. Tony has been a speaker and
expert panel participant discussing cybersecurity topics across European and US
security conferences including Health-ISAC & ISACA events.

He holds a M.Sc. in Security and Forensic computing and an M.Sc. in Artificial
Intelligence, a post-graduate certificate & M.Sc. in Artificial Intelligence,
drug development and numerous IT, cybersecurity, privacy and artificial
intelligence qualifications.





This session will explore risks associated with Generative Artificial
Intelligence and outline examples of GenAI can be used to derive benefit while
minimising risks.


CHRISTOPHER NEASHAM

GLOBAL PROCUREMENT MANAGER - ALMAC GROUP

"IMPACTING CHANGE IN OUR SUPPLY CHAINS FOR SUSTAINABILITY GAINS"

Speaker Bio Synopsis



Chris has over 10 years' experience in pharmaceutical and laboratory procurement
and is currently responsible for all procurement activities in Almac Sciences
and Arran Chemical Company. He is MCIPS qualified having studied procurement and
supply chain with the Chartered Institute of Procurement & Supply.





How we can take ownership of our internal business practices to create tangible
supply chain environment improvements, whether from the materials we consume or
the processes we are responsible for.


SIOBHAN FLEMING

PHARMACEUTICAL DIGITALISATION CONSULTANT - SIEMENS

Speaker Bio



Siobhan brings over two decades of experience in the pharmaceutical industry,
spearheading the adoption of cutting-edge technologies within the life sciences
sector. In her role with Siemens, she is a leading figure in the implementation
of digital consulting solutions for the pharmaceutical industry, with a primary
focus on simulation, digital twin applications, and process development.
Siobhan's responsibilities include overseeing and optimizing operations
throughout the end-to-end pharmaceutical product lifecycle from process design
to engineering to operations. Her role encompasses a strategic emphasis on
employing advanced data analytics to enhance efficiency, quality, and innovation
across diverse processes.


SUSAN COSTELLO

SKILLNET NETWORK DIRECTOR - BIOPHARMACHEM SKILLNET

Speaker Bio



Susan has over 25 years’ experience in Learning and Development and 17 years as
a Skillnet Network Manager.
Susan works with a variety of companies to establish and integrate learning and
development as part of the organisations strategic plan, developing skill sets
and helping businesses in the sector overcome the challenge of sourcing,
developing and retaining talent.


EVIN ALLEN

LECTURER IN INDUSTRIAL PHARMACEUTICS - UNIVERSITY COLLEGE CORK

"THE DEVELOPMENT OF A MULTIDISCIPLINARY PROGRAMME AND T-SHAPED GRADUATE TO MEET
INDUSTRIES NEEDS"

Speaker Bio Synopsis



Evin is a pharmacist with a doctorate in microneedle vaccine development (PhD,
UCC) as well as a special purpose award in Lean Sigma (Blackbelt, MTU). Evin has
considerable industrial experience working with a number of multinational
(bio)pharmaceutical companies both in Ireland and internationally in technical
leadership roles. Evin is experienced in drug product manufacture for
biopharmaceuticals, product characterization and knowledge management as well as
process troubleshooting. Evin was appointed as lecturer in Industrial Pharmacy
in the School of Pharmacy as part of the iEd Hub project in 2022 and is the
programme director for the MSc in Industrial Pharmaceutical Sciences, Operations
and Management and MRes in Industrial Pharmaceutics in UCC.





The School of Pharmacy UCC & iEd Hub have launched a new MSc programme in
partnership with regional pharmaceutical companies. The objective of this
programme is to develop a T-shaped graduate with deep sectoral technical
knowledge complemented with broad transverse skills. The programme, curricula
and delivery has been specifically designed to ensure graduate employability and
minimise graduate time to competency in the workplace. A multidisciplinary
programme team from Pharmacy, Management & Marketing and Business Information
Systems was formed to deliver this objective. A key pillar of the teaching
delivery is the experiential learning through laboratory practicals where
students were assigned to work in teams to install, operate and optimise pilot
scale pharmaceutical equipment in simulated environments in the School of
Pharmacy


JENNIFER BAILEY

SENIOR TECHNICAL WRITER - TWI

"HOW INTELLIGENT CONTENT CAN SUSTAINABLY UNDERPIN INDUSTRY 5.0 MANUFACTURING"

Speaker Bio Synopsis



Jennifer has over 15 years project management and technical writing experience
in pharmaceutical and medical diagnostic cGxP environments. She has worked for
companies such as Amgen Technology Ireland, Abbott Ireland Diagnostics Division,
Allergen Ireland and Trinity Biotech across the Manufacturing, Quality,
Technical Transfer, Product Development, Regulatory and Maintenance and
Engineering Departments. In addition to technical writing, her main areas of
expertise include workflow management, process improvement, root cause analysis,
impact assessment, change control and risk assessment. Jennifer joined the team
at TWi in 2023 to combine her knowledge of the life sciences manufacturing
sector and passion for continuous process improvement with TWi’s intelligent
content authoring solutions for the Biopharma and Life Sciences sector.





In this talk, we embark on a journey through the evolving landscape of digital
transformation in the life sciences sector, where Industry 5.0 principles and
the synergy of human intelligence and machine capabilities transform your
content from static to intelligent assets, while also becoming a driving force
in addressing content-related challenges resulting in significant commercial
savings for your business, while also supporting sustainability initiatives.
After years of digital transformation projects within life sciences companies
and many moving from paper to digital, the creation of SOPs and other
documentation in MS Word remains largely unchanged since the 1990’s. As Industry
5.0 emerges, there is a strong focus on humans and machines working together to
drive more resilient and sustainable manufacturing practices. In a demanding
business world where there is increased pressure to shorten the time to bring
new products to patients in a profitable and sustainable way, while satisfying
increasing regulatory requirements, intelligent content is a game changer that
most life science companies are only discovering today! For well over a decade,
technology companies across many industries, including highly regulated sectors
such as finance, have experienced the positive impact of intelligent content.
Traditionally, these companies had large silos of thousands of documents that
were inefficiently created by hundreds of people dispersed all over world using
tools such as MS Word. Today, the principles of Industry 5.0 support companies
not only to embrace intelligent content but also in the efficient development of
content that can be easily and seamlessly re-used across the entire business
establishing a ‘single source of truth’. As Gartner predicted, life science
companies are now starting to adopt this well-established combination of
technology, process, and content strategy to implement intelligent content as
part of their digitalisation efforts. At the end of this talk, you will gain
insights into how intelligent content can solve not only your content related
challenges, but also contribute to resolving operational, regulatory, and
business issues. Additionally, you will be equipped with valuable information on
where to seek further guidance in this transformative journey.


RAHEL BAILIE

CONTENT SOLUTIONS DIRECTOR - TWI

"HOW INTELLIGENT CONTENT CAN SUSTAINABLY UNDERPIN INDUSTRY 5.0 MANUFACTURING"

Speaker Bio Synopsis



Rahel is the Content Solutions Director at TWi. She brings with her a strong
background in developing successful digital content strategies, tackling the
complexities of managing content for clients globally. With an aim of using
content to deliver better experiences and increase the ROI of product lifecycle
content, she applies the principles behind intelligent content to deliver
operational efficiencies in a scalable, sustainable way. In her 20+ years of
consulting, Rahel has worked with many global companies, including Welch Allyn
and A-dec Dental. Rahel is a recognised thought leader, having authored and
contributed to several industry books, magazines, and academic journals. She
presents at events worldwide and also teaches in the Content Strategy Master’s
Program at FH-Joanneum in Austria.





In this talk, we embark on a journey through the evolving landscape of digital
transformation in the life sciences sector, where Industry 5.0 principles and
the synergy of human intelligence and machine capabilities transform your
content from static to intelligent assets, while also becoming a driving force
in addressing content-related challenges resulting in significant commercial
savings for your business, while also supporting sustainability initiatives.
After years of digital transformation projects within life sciences companies
and many moving from paper to digital, the creation of SOPs and other
documentation in MS Word remains largely unchanged since the 1990’s. As Industry
5.0 emerges, there is a strong focus on humans and machines working together to
drive more resilient and sustainable manufacturing practices. In a demanding
business world where there is increased pressure to shorten the time to bring
new products to patients in a profitable and sustainable way, while satisfying
increasing regulatory requirements, intelligent content is a game changer that
most life science companies are only discovering today! For well over a decade,
technology companies across many industries, including highly regulated sectors
such as finance, have experienced the positive impact of intelligent content.
Traditionally, these companies had large silos of thousands of documents that
were inefficiently created by hundreds of people dispersed all over world using
tools such as MS Word. Today, the principles of Industry 5.0 support companies
not only to embrace intelligent content but also in the efficient development of
content that can be easily and seamlessly re-used across the entire business
establishing a ‘single source of truth’. As Gartner predicted, life science
companies are now starting to adopt this well-established combination of
technology, process, and content strategy to implement intelligent content as
part of their digitalisation efforts. At the end of this talk, you will gain
insights into how intelligent content can solve not only your content related
challenges, but also contribute to resolving operational, regulatory, and
business issues. Additionally, you will be equipped with valuable information on
where to seek further guidance in this transformative journey.


PETER BLENNERHASSETT

CEO & CO-FOUNDER - BLYNKSOLVE

"A UNIFIED KNOWLEDGE SPACE - ACCELERATING TECH TRANSFER"

Speaker Bio Synopsis



Peter Blennerhassett is the CEO and Co-Founder of Blynksolve, a software company
based in Dublin. Peter graduated from Chemical and Bioprocess Engineering UCD
and has worked as a Process Engineer in Pfizer and MSD in roles such as TechOps,
Person-in-Plant and Tech Transfer. He is driven by scalable simplification of
Pharma Manufacturing and the smart use of technology to achieve this. The
concept of a Unified Knowledge Space developed by Peter and Blynksolve was
awarded “Innovation of the Year” at the 2023 Pharma Industry Awards. Peter is
also proud to serve as a committee member of the ISPE Irish Affiliate and
Engineers Ireland Chemical and Process Division.





In this presentation, Peter Blennerhassett CEO of Blynksolve will explore the
concept of a Unified Knowledge Space (UKS) for Pharmaceutical manufacture. The
novel concept of a UKS was recently awarded "Innovation of the Year" at the
Pharma Industry Awards 2023 voted by industry peers. Peter will examine current
challenges in the Pharma industry, how other industries have addressed these
challenges and how a UKS can help make Pharma Production more agile, resilient
and efficient.


SEAMUS BUTLER

MANAGING DIRECTOR - ACS DRIVES

"HARMONICS AND POWER QUALITY IN LIFESCIENCES"

Speaker Bio Synopsis



Seamus Butler: Managing Director for ACS Drives and Control Systems, Ltd - the
leading Drives solutions provider to Irish industry. ACS Drives and Control
Systems are a Gold Standard member of ABBs Authorised Value Provider Program,
which is a global network of approved and certified ABB Partners. We offer the
complete range of ABB Variable Speed Drives as well as installation,
commissioning, maintenance and lifecycle support. ACS Drives and Control Systems
are also Ireland's only ABB certified commissioning and repair specialists and
through our recently launched Digital Transformation Hub, we will be developing
and delivering the ABB Ability Powertrain suite of digital solutions in Ireland.
The ABB Ability™ Digital Powertrain includes devices, software and services,
combining connectivity and data analytics with ACS Drives expertise and superior
services to render their clients' operations more efficient, predictable and
safe. Through our unique and extensive experience across sectors, we offer
unrivalled solutions and support at every stage of a construction project; from
specification and design, through installation and commissioning, and ongoing
maintenance by the most responsive service division in the sector from our
central strategic base in Mullingar. Our team is acknowledged as the best in the
business and have experience in all industrial sector, from Cement and Chemical
to Pharma, Food and Beverage, Utilities and Tech.





What are harmonics. Where do they come from. Side effects, consequences,
efficiencies. Power quality. Harmonic Mitigation techniques. Comparisons.
standards.


GER CARTON

CEO - PLANTQUEST

"VISUALISING THE BROWNFIELD"

Speaker Bio Synopsis



Ger Carton is the co-founder and CEO of PlantQuest, a software company enabling
the world’s largest pharmaceutical companies and other large process facilities
to digitally transform their asset management operations through the provision
of intelligent asset mapping and geo-optimized workflows. Prior to this, Ger
gained over two decades of experience working across a range of disciplines
within the leading Pharmaceutical, Medical Devices, and Oil & Gas companies. No
stranger to the challenges and opportunities faced in digitizing and bringing
visual context to a range of brownfield facilities, Ger shares his learnings and
experiences in the matter from both the perspective of the buyer and the vendor.





In a landscape where the premium digital solutions are focused on new
facilities, Ger Carton highlights some of the key challenges facing brownfield
facilities. These large, complex facilities are marked by their use of diverse,
often isolated systems and high worker turnover, leading to fragmented data, a
lack of unified decision-making, and a loss on operational efficiency. Ger
highlights the challenges of visualizing this data and shares insights from both
the end-user and vendor perspective. Emphasizing the criticality of
visualization, Ger discusses its tangible ROIs, the value proposition, and the
anticipated timelines in bringing visual context to workflows in this landscape.
He offers guidance for end-users, ensuring positive outcomes from visualization
initiatives, and concludes by suggesting actionable next steps for organizations
aiming to enhance their brownfield visualization and digitization efforts.


DAMIEN COSTELLO

DIRECTOR OF LIFE SCIENCES - EXPLEO GROUP

PAUL COYNE

VICE PRESIDENT - BUSINESS DEVELOPMENT - ENVETEC SUSTAINABLE TECHNOLOGIES

"RETHINKING WASTE: SUSTAINABLE TREATMENT OF BIOHAZARDOUS MATERIAL"

Speaker Bio Synopsis



Paul Coyne is Vice President of Business Development for Envetec. Envetec is an
Irish company with a global vision to create clean change. Paul gained his BSC
from UCD and moved from University to roles covering both Laboratory and QA with
the Kerry Group. Following this he joined Technopath Distribution in 2005 as a
Technical Sales representative and ultimately covered roles of increasing
responsibility before becoming Business Development Manager. In 2015 Paul joined
IDEXX Laboratories where he was Sales Manager for Europe and various
Distribution territories. His experience includes Pharma, Med-Device ,Food And
Beverage as well as extensive knowledge of the Veterinary sector. Paul is
passionate about creating clean change and is confident that we can have
positive environmental impact by responsible treatment of Laboratory
Biohazardous waste. Paul joined Envetec in 2022 and has recently become a My
Green Lab Ambassador and a member of the International Solid Waste Association.





In the interest of efficiency, accuracy and infection control the Life Science
sector has become reliant on single-use materials. While this material presents
a lot of benefits it also creates a lot of significant issues, specifically in
it’s disposal. Currently, this material is treated as waste once used and
therefore is disposed, usually through extremely Carbon intensive methods.
Envetec are tackling this issue head on by looking at this used biohazardous
material as a resource. Through the use of innovative technologies it is now
possible to unlock opportunities such as recycling for this used material all
while treating it in an effective and sustainable manner.


NEEHARIKA DAYYALA

PRINCIPAL BUSINESS CONSULTANT - EXPLEO GROUP

"AI & BEYOND: EVOLVING CSV & CQV"

Speaker Bio



Neeharika Dayyala is an MBA and a Biomed graduate with over 10 years of
experience in Life Science industries while also being exposed to different
cultures and people from different countries. Neha has previously worked in
Deloitte India in the Life Sciences and Healthcare Industry before moving to
Deloitte Ireland to be part of their still new Life Sciences practice. Neha has
worked in resolving various aspects of the workspace in improving the safety and
quality for people. Neha has also authored an Agile POV, which is published on
the Deloitte Website and a blog for Expleo on the future of automation in
validation.


PAUL DENNY-GOULDSON

CHIEF SCIENCE AND TECHNOLOGIST - ZIFO

"TRANSFORMING ELECTRONIC BATCH RELEASE – PROCESS ORCHESTRATION AND INTEGRATING
ERP, QC LABS TESTING AND PRODUCT RELEASE - EFFICIENCY AND PROCESS INSIGHTS."

Speaker Bio Synopsis



Paul has built up extensive experience in a broad range of scientific
informatics and data management domains spanning research, development,
manufacturing and clinical studies in Pharma/Biotech, FMCG, Chemical, Food & Bev
and Oil & Gas organizations. He has over twenty years of experience with global
scientific informatics products, during which time he also founded several
companies focused on combining science & technology. He started his career as a
Post Doc and subsequently Senior Scientist at Sanofi-Synthelabo Toulouse (now
Sanofi) for just under five years, where he managed a multidisciplinary
molecular and cell biology group. Paul obtained his Ph.D. in Computational
Biology from Essex University.





Discussions, case studies and ideas on how BPMN technology can help orchestrate
existing processes, leverage existing infrastructure and provide great insights
into the EBR process.


DAVID DOYLE

SALES ENGINEER - BUTLER TECHNOLOGIES

"SEE WHAT YOU CANT SEE AND CANT REAR."

Speaker Bio Synopsis



David Doyle, level 3 thermographer, level 1 ultrasound, 18 years with Butler
Technologies providing training in thermal imaging and ultrasound testing





Using thermal imaging cameras to see heat coming from equipment and products
before they get to temperatures that would damage them. Use ultrasound to see
where leaks in pressurised pipelines or room seals are leaking.


PATRICK FALVEY

PRINCIPAL CONSULTANT - LATHAM BIOPHARM GROUP

"ECO-FRIENDLY MANUFACTURING"

Speaker Bio



Patrick Falvey has over 30 years of research, managerial and technical
experience in the Pharmaceutical and Biotechnology Industries. He has enjoyed
various positions of responsibility and leadership in Operations, Quality
Assurance, and Compliance and believes in collaboration among individuals and
groups to effect positive change and improvement.



Patrick has previously been a Senior Team Lead for Pfizer with responsibility
for the manufacture of Prevnar 13 vaccine, (prevention of pneumococcal
meningitis) one of the world’s most successful vaccines. He has hosted and
responded to various agency audits including FDA, EMA, SFDA (China) and was
responsible for overall Department Inspection Readiness program. He has led and
been responsible for a team of Investigation and Compliance specialists that
closed hundreds of investigations and commitments to maintain state of
compliance. He has onboarded & designed GMP training programs for new college
graduates for introduction to Aseptic & Cleaning Qualification programs to
support multiple aseptic manufacturing lines and has managed site GMP
Training/Safety programs. Patrick has worked with a variety of companies ranging
from large pharmaceutical companies to start-up ventures.



Patrick received his Bachelor of Science in Biochemistry from University College
Cork in Ireland, Masters of Science (Industrial Pharmacy) from Long Island
University in Brooklyn, and his Master of Business Administration from Iona
College in New Rochelle NY.


STEVEN FLYNN

CHIEF PILOT EU - SPRIGHT

"DRONES IN HEALTHCARE AND PHARMA"

Speaker Bio Synopsis



One of Ireland’s first commercially licensed drone pilots, Steven has spent the
last 11 years leading some of Ireland’s cutting edge drone operations including
delivering a parcel for An Post in 2018 (5km), Diabetes Medicine to the Aran
Islands (18km) in 2019, and high-end filming for major motion pictures and
broadcast networks. He has spoken on compliance and safety in the drone industry
at conferences around the world, and is now Chief Pilot for Spright’s EU
operations.





Drones have long been touted as the next great thing in logistics but to date
have not lived up to the hype. 2024 will be the year we see unmanned cargo
aircraft begin to have real impacts on healthcare and critical healthcare
industries like drug manufacturing and distribution. Learn about what’s happened
in the sector and how unmanned medical drones can impact healthcare in Ireland.


DR. MATTHEW HALEY

ACCOUNT MANAGER - DUBLIN & NORTH-WEST UK - ZEISS

"SOLUTIONS, TOOLS AND TECHNOLOGY DEVELOPMENT FOR BIOTECH AND PHARMA COMPANIES
BOTH OLD AND NEW"

Speaker Bio Synopsis



Dr Matthew Haley, is the ZEISS Account Manager for Dublin and North-west UK,
since 2016. Matthew has a PhD in Physiology and years of experience connecting
industry requirements with powerful research solutions.





ZEISS has a host of solutions that enable pharma and biotech companies to
overcome difficulties, boost productivity and innovate discovery. This talk
provides an introduction to advanced automated microscopy imaging systems and
powerful vendor-agnostic image analysis software with Deep Learning A.I. tools.
Furthermore, ZEISS can provide optical components for your products, or
customize software solutions, and even invest in technology-driven start-ups in
this sector.


BRIAN HARRISON

MANAGING DIRECTOR - HITECH HEALTH

"ARE ADVANCED MEDICINES INCLUDING CELL AND GENE THERAPIES THE FUTURE OF
MEDICINE?"

Speaker Bio Synopsis



Brian Harrison is Managing Director of Hitech Health , A CDMO with a focus on
the development and manufacture of Advanced Medicines including Cell and Gene
Therapy Products. Brian was previously an executive at Bristol Myers Squibb
where he was VP of Development based in the US. He also was General Manager of a
Biopharmaceutical Manufacturing plant for Bristol Myers Squibb in Ireland. Brian
holds a BSC and PH.D from University College in Dublin and also carried out Post
Doctorate research at Emory University, Atlanta, GA USA





Advanced Medicines make up more than 10% of total new drug approvals in the US
as of early December. These novel therapies can transform peoples lives often
with as little as a single dose. However, there are many challenges before these
new medicines will become standard of care, not least of which is the extremely
high cost per dose which can extend to >$3M dollars for the most expensive
treatments. This presentation will give an overview of advanced medicines,
outline some of the challenges but also opportunities provided by this fast
growing area of new medicines


PADRAIG HYLAND

CEO - THE CORE STORY

Speaker Bio



Padraig is passionate about what he does and leans naturally to facilitating,
producing and delivering keynotes at international conferences and events
worldwide. His unique blend of human insight, extensive business career and
background as a comedian makes him truly unique.
Padraig is a TEDx Speaker and has featured on BBC and TV3. He has written and
presented 22 episodes of the Ninja Leadership Academy for Meet The Boss TV.
Padraig is a story marvel and is the driving force behind The Core Story, a
company that works with global organisations around transformational change
while helping leaders reimagine their business in the context of new change
drivers such as ESG, Sustainability, and the Pace of Change.
In the Bio Pharma world, The Core Story focuses on change, 360-style, taking
their clients through an innovative process, enabling them to tell their
authentic story in a way that connects with the hearts and minds of all
stakeholders.
Padraig's experience spans twenty years as an international business
professional in Asia, USA and Europe for global organisations such as Baxter
Healthcare and his work continues today to include companies like illumina,
Takeda, Janssen.
He passionately believes that we need more heart in business strategy and guides
leaders and organisations on how to reimagine their business in a way that opens
up new possibilities for the future and changes performance.
Padraig and his team have developed innovative and unique frameworks and tools
that have evolved alongside global clients. These have been successfully applied
in various scenarios, empowering organisations from all corners of the business
world to thrive in a fast-changing world.


PETER KELLY

CEO - PHARMAFILTER GROUP HOLDINGS

"PHARMAFILTER ADVANCED PURIFICATION OF PHARMACEUTICAL WASTEWATER AND
DECONTAMINATION OF WASTE ON-SITE."

Speaker Bio Synopsis



He worked with Heineken and Guinness in senior commercial roles and with
Metabolix/ADM in a global technical and commercial role in the Bioplastic sector
on applications in the Agriculture, Horticulture, Marine, Erision Control,
Wastewater, and other sectors, including working with several US Universities on
contamination of soil. His educational background covers business
administration, advanced polymer sciences, the conversion of second-generation
feedstocks to green chemicals, and the environmental impact of wastewater. He
has published several white papers, of which his latest in 2023, "Contamination
of Hospital Wastewater," he is a fellow of the All Ireland Business Foundation.





Pharmafilter advanced purification of Pharmaceutical and Hospital wastewater and
decontamination of waste on-site. The outbreak of the COVID-19 pandemic directed
global attention towards monitoring viruses and other infectious pathogens in
hospital wastewater and waste, and yet this effluent continues to impose a
serious and escalating threat to public health. The concentration of analgesics,
antibiotics, β-blockers, hormones in hospital effluent has been found to be much
higher compared to their concentrations in domestic wastewater. The presence of
various recalcitrant organics and pharmaceutically active compounds in
healthcare wastewater also imparts a complex pollution load to water resources
and ecosystems. In their day-to-day business, hospitals discharge wastewater
containing large amounts of pharmaceuticals, metabolites and cytotoxins as well
as pathogenic contamination. Many of the micropollutants present in hospital
wastewater are highly toxic and what's more, their strong chemical compounds
often and their way, untreated, into the public infrastructure, where they
remain biologically active. The interaction between these discharges including,
untreated Pharmaceutical production discharge wastewater, to local wastewater
treatment plants and their broader environment, is an area of growing concern,
particularly in the context of eco-toxicity and antibiotic-resistant bacteria.
Due to technical and economic constraints, it is not possible to remove this
contamination at a receiving wastewater treatment plant because of the
specialist removal techniques required. Since pharmaceuticals are, by design,
intended to interact with living organisms, even very low environmental
concentrations are a concern.


JASON KELLY

APPLICATIONS DIRECTOR - LIGHTHOUSE WORLDWIDE SOLUTIONS

"EU GMP ANNEX 1: CONTINUOUS ENVIRONMENTAL MONITORING CHALLENGES IN THE
CLEANROOM"

Speaker Bio Synopsis



Jason Kelly is Director of Applications at Lighthouse Worldwide Solutions and is
based in Oregon USA.

With over 28 years’ experience in providing Cleanroom Monitoring Solutions to
the Cleanroom Industry, Jason specializes in Pharmaceutical, Medical Device,
Life Science, Semiconductor, Aerospace and Military Cleanroom applications.

Jason presents worldwide on current cGMP, cleanroom standards and Environmental
Monitoring Systems from risk management, system designs, using GAMP protocols,
system installations, validation processes, customer training and system service
support SLA’s.

He is a faculty member of the Institute of Environmental Sciences and Technology
USA (IEST) and delivers regular IEST training courses and presentations on
Cleanroom Standards and technologies concerning environmental monitoring and
contamination controls in cleanrooms.

Jason is a new committee member of PDA Ireland, an ISPE member and volunteer as
well as a committee member of the Irish Cleanroom Society and a member of the
International Confederation of Contamination Control Societies (ICCCS) working
on ISO 14644 family of standards.





Review of EU GMP Annex 1:2022 Environment Monitoring requirements and the
challenges of meeting continuous manufacturing and moving into a Pharma 4.0 and
beyond. This presentation will look at existing and new EM monitoring
technologies in Aseptic Sterile Processes. How do we move forward into the
digital age and how do we obtain meaningful EM data and mitigate against product
contamination. How are we monitoring today and how are we intending in
monitoring tomorrow to fit into a Contamination Control Strategy. Learn how to
apply current ISO standards and how to develop a continuous EM program and EM
system. This presentation will also review ISO 14698, EN17141 and provide an
update on the draft ISO 14644-20 standard on Microbial Contamination Control.


VIKRAM KUNNATH

TECHNOLOGY CONSULTING PARTNER - EY

Speaker Bio



Vikram Kunnath is an Technology Consulting Partner at Ernst and Young in Ireland
based in Cork. He leads up EY'S Digital Manufacturing Practice for UK & Ireland
supports Manufacturing / Supply chain initiatives for clients in the
Lifesciences industry . Vikram has around 26 years of work experience with
Global Lifesciences clientele having lived in Asia, Germany, US and now calls
Ireland

his home.



He possesses strong Process background in the Manufacturing realm with in-depth
understanding of Lifesciences API, Formulation, Vaccines space and. He and his
team support work for Lifesciences clients in Europe around themes like IT/OT
convergence, Industry 4.0 Digital maturity assessments and
Consulting/Implementation of shopfloor technology like Manufacturing execution
systems, Distributed Control systems, Laboratory information management systems,
Quality management systems, OT Cybersecurity, Manufacturing analytics, AR/VR
technologies among others.



Prior to joining EY 2 years ago, Vikram has incremental stints in with global
consulting and product firms like Siemens, Tata Consultancy services and
Cognizant and also worked with GE Healthcare Lifesciences division ( Cytiva now
) for few years supporting their Bioprocessing units


TERRI LOVE

SENIOR MSAT BIOMANUFACTURING ENGINEER - MERCK LIFE SCIENCE

"IMPACT OF INTENSIFIED BIOPROCESSING ON SUSTAINABILITY"

Speaker Bio Synopsis



Terri Love is a Senior Biomanufacturing Engineer within the Manufacturing and
Sciences Technology team at Merck KGaA, based in Ireland. Following a BSc degree
in Industrial Biochemistry from the University of Limerick, Terri worked for
Lonza Biologics in the UK before returning to Ireland to work with Merck.

Terri has been employed within the biopharma industry for the past 21 years, and
she has been working for 18 years as a field-based Biomanufacturing Engineer at
Merck in Ireland. During her time at Merck, Terri has been collaborating with
Irish biopharma customers on their technology transfers, scale-up and
implementation





With the move of the biopharmaceutical manufacturing industry towards Biopharma
4.0, the focus has also been on increasing the efficiency and utility of such
processes. This has led to a drive towards continuous processing in the long
term for processes where it is appropriate and an intensified bioprocessing
approach to the others. Whilst the economic impacts are well understood with
such approaches, there is limited data on how these new efficiencies contribute
to sustainability metrics. This talk will provide an overview of the
sustainability metrics commonly used, key sensitivities and a case study with a
downstream intensified process.


DESMOND O'SULLIVAN

VP BUSINESS DEVELOPMENT - OPTEL GROUP

"THE FUTURE OF GLOBAL SUPPLY CHAINS"

Speaker Bio Synopsis



A professional with over 35 years’ experience working at the highest level in
the Pharmaceutical, Lifesciences, Warehouse and Logistics, Food and Beverage,
CPG industries. I am responsible for the Global PMO at Optel Group but now due
to the Climate Crisis I am involved with Business Development with specific
responsibility for the Climate Change Strategic alignment within the EMEA
region.





Presentation to discuss Global Supply Chain challanges and opportunities for
Business.


MARTIN O’NEILL

ASSISTANT LECTURER - ATLANTIC TECHNOLOGICAL UNIVERSITY

"COMPARISON OF MACHINE LEARNING AND CLASSICAL STATISTICS IN PREDICTING HEALTH
OUTCOMES IN A LIFESTYLE MODIFICATION PROGRAMME FOR OBESITY."

Speaker Bio Synopsis



Martin O’Neill is an experimental neuropsychologist by trade: he was awarded an
Honours Degree in Neuroscience from the University of Glasgow (2000) and a PhD
in Psychological Science from the University of St Andrews (2005), Scotland.



Following his studies, Martin was a Research Associate at the University of
Cambridge (2005-2014), a Senior Research Associate at the University of Oxford
(2014-2019), and a Research Fellow in Neural Data Science at the University of
Nottingham (2020-2022), England. Following on from a six-month stint as an
Assistant Lecturer in Psychology at IT Sligo (2021-2022), he is now Assistant
Lecturer in Population Health Informatics and Statistics at ATU Sligo (since
2022), Ireland.



Martin's research focuses on the neural mechanisms underlying learning and
decision making. He is currently analysing a large-scale neural dataset
collected while in Oxford with the analysis techniques developed while in
Nottingham. While in Oxford, Martin was a Lecturer in Psychology at St Hugh’s
College (2016-2021) and Brasenose College (2019-2021) and accredited as an
Associate Fellow of the Higher Education Academy (HEA). At ATU Sligo nowadays
Martin teaches statistics, IT, and data science in the Dept of Health and
Nutrition.





Obesity rates are rising globally as are the associated healthcare and societal
costs. Lifestyle intervention programs have been accepted globally as a suitable
population-level approach to obesity and its complications. We compared machine
learning techniques with classical statistical models in predicting health
outcomes in a structured lifestyle modification programme to determine whether
machine learning could be a useful adjunct in obesity research. Machine learning
analysis was largely in agreement with the standard statistical models, with
both indicating gender, age and distance travelled to the intervention centre
positively predicting weight loss. However, in addition, factors worthy of
future investigation were identified by machine learning including BMI;
depression; number of days between being referred and starting the intervention.
We propose a potential hybrid approach combining the strengths of traditional
statistics with the advantages of machine learning as adjunctive tools in
obesity research.


GRAHAM O’REILLY

PROJECT MANAGER - CAMFIL

"FAN FILTER UNITS FOR CLEAN PROCESSES"

Speaker Bio



Graham has been with Camfil for over 25 years and has been involved in all
aspects of the air filtration industry during this time. He is presently project
manger and product manager for the Life science industry. He is heavily involved
in clean process design from cradle to grave in conjunction with all the
engineering houses and then continuing the processes on site with both the
contractors and end users (Pfizer, Abbvie, Takeda, BD, Regeneron, Amgen, West
pharma). Recent projects involving fan filter units included the turnkey package
of ceiling grid, FFU’s, Filters and most importantly the controls systems.
Graham is extremely knowledgeable on all the controls used in driving these
units from Modbus to LON.


BARRY O’SULLIVAN

CHAIRMAN - SHANNON ESTUARY ECONOMIC TASKFORCE

FRANK SAGE

EU BUSINESS DEVELOPMENT MANAGER - EXERGY LLC

"SAFE, STERILE, SUSTAINABLE & SMART WFI DISTRIBUTION WITH EXERGY POINT-OF-USE
COOLING SYSTEMS"

Speaker Bio Synopsis



Frank has over thirty years’ experience in the Specification of Fluid Handling
Equipment for the Pharmaceutical and Process Sectors in Ireland and the EU.
Fulfilling the detailed specification, supply, and regulatory requirements of
new fluid handling technologies, on major Biopharmaceutical and Process Projects
from conception to final qualification.





A fresh look at why, choosing a Zero-Ambient WFI Loop, is proving to be the best
solution to address the competing demands of Regulatory Compliance, Employee
Safety, Sustainable Manufacturing, and Return on Investment.


BHARAT SHARMA

CEO & FOUNDER - MONSOON CONSULTING

"THE DIGITAL SHIFT: ACCELERATING B2B COMMERCE IN BIOPHARMA"

Speaker Bio Synopsis



Bharat Sharma is the Founder and CEO of Monsoon Consulting, Europe’s leading
Digital & eCommerce agency with clients including Uniphar, Heat Merchants, and
Sysco Ireland. Bharat is a leading figure, author and frequent speaker at events
across Europe and India relating to eCommerce technology, industry trends, and
government sectors.





Unlock the power of digital transformation in biopharma and life sciences
eCommerce. Tailored for B2B commerce leaders, our talk brings decades of
enterprise digital expertise to the forefront. We'll showcase how strategic
digital integration can boost revenue, streamline sales, and future-proof your
business. Don't miss this chance to reshape your B2B strategy with cutting-edge
insights.


LEE SHERLOCK

CEO & CO-FOUNDER - META-FLUX

Speaker Bio



Lee Sherlock is the CEO and Co-founder of Meta-Flux, a group that is focusing on
enhancing the interface between AI and systems biology in drug development
settings with an emphasis for oncology. Prior to Meta-Flux, Lee spent multiple
years as a biochemist aiding in drug development. Lee has a particular interest
in AI and personalised medicine with recent publications in Frontiers of
medicine.


LAURA STAKELUM

MANAGING DIRECTOR - STAKELUM CONSULTANCY

RONAN STAUNTON

MANAGING DIRECTOR - HEALTHFIELD CONSULTING

"THE MICE PRINCIPLE. 4 PRACTICAL WAYS TO BUILD A SUSTAINABLE SUPPLY CHAIN IN
HEALTHCARE"

Speaker Bio Synopsis



Ronan Staunton has over 20 years of experience in the healthcare sector, leading
projects for Global brands such as Nutricia Medical, Abbott, Medtronic & others.
Ronan spent 7 years as The Global Head of the Critical Care Division for
Nutricia Medical, which is a division with €700m revenue and covers a range of
tube feeding products, medical devices and digital technologies. Following this,
he spent 3 years as head of the MedTech Division of PCH International, a Global
Product Development business with offices in Ireland, The USA and China. In
2023, Ronan set up Healthfield Consulting which is a Global consortium of supply
chain consultants supporting MedTech & Healthcare companies to optimise their
supply chain and reduce their carbon footprint. Ronan is a consultant member of
international advisory boards on sustainability and is Policy Advisor for Smart
Grid Ireland, an All-Ireland representative body for the Irish energy sector.





Just 7 hours of anesthesia with desflurane is the equivalent of a 15,700 km car
journey in terms of emissions! The unique requirements of the healthcare sector
(single use items, sterile packaging, vast volume supply chains) means that the
industry has a hugely negative impact on the environment and 80% of Carbon
emissions from the sector come from its supply chain. While all Medical and
healthcare companies have an obligation to limit their environmental impact,
this must be balanced by the regulatory requirements of the sector & commercial
goals. There are 4 simple principles to MICE and applying these can bring
practical changes to supply chains and have a really positive impact on
emissions. M – Measure: If it’s not measured, it’s not managed! I – Investigate:
Every organisation is different. Where are your environmental problem areas? C –
Communicate: Effective communication is critical for sustainable success E –
Engage: Work in collaboration with partners (manufacturers, sub-contractors,
freight forwarders) for optimal results


DONAL SULLIVAN

CEO - COMPUCAL CALIBRATION SOLUTIONS

"GO DIGITAL & MOBILE FOR COMPLEX WORKFLOWS"

Speaker Bio Synopsis



Donal Sullivan is CEO of CompuCal Calibration Solutions - SaaS calibration &
maintenance management specialists. A highly experienced and successful business
leader, he has spent 25 years+ in the technology sector with Apple, Flextronics
and Johnson Controls, where he led the Ireland organisation, establishing a
global business services center and a digital engineering function. Donal has
built a number of digital businesses, run complex global operations, delivered
smart buildings and campuses globally. An expert in SaaS/AI offerings and
solutions for end clients he has assisted global corporations with their digital
transformation needs. Donal now leads CompuCal - a world leader in instrument
calibration, maintenance and validation management working with some of the
largest global brands and manufacturers, servicing SMEs to Fortune 500 companies
within the regulated industry sector as well as calibration service companies.
In addition to this, Donal is the current Chair of MCCI (Microelectronic
Circuits Centre Ireland) - a large scale microelectronics technology centre,
hosted at Tyndall National Institute, focused on delivering high impact
microelectronic research, driven by global industry application needs.





To enable digital transformation and to take paper out of complex processes, you
need some key enabling technology Cloud architecture and platform Ability to
profile and capture the complex workflows, logically and digitally Real-time
processing of data Useful tools and technology at point of use Bring context to
the user in real time Enable the use of mobile phones as a digital tool, while
protecting data privacy & security,


KIERAN TOWEY

HEAD OF APPLIED INTELLIGENCE - KPMG IRELAND

"DATA & AI, THE NEW SILVER BULLET?"

Speaker Bio Synopsis



Kieran Towey, Managing Director Data Scientist and KPMG Analytics lead Kieran
has 25 years’ experience working as a Data Scientist, delivering data powered
solutions to large global and domestic clients. Kieran has a mathematics and
statistics academic background and 20 years experience working as a Management
Consultant in the field of Advanced Analytics & AI. Kieran’s particular
expertise lies in designing and delivering data powered solutions that maximise
the client value. Of late, Kieran is working closely with clients to understand
the applications of AI and in particular Generative AI and how these
capabilities may impact the future of work and can deliver business value.





The talk addresses the potential of AI to transform the industry. Going beyond
the hype, what are the keys to unlocking business value.


GARY TYNE

DIRECTOR - PRO-RELIABILITY SOLUTIONS LTD

"IS YOUR ASSET STRATEGY OPTIMIZED FOR LOWEST COST AND RISK?"

Speaker Bio Synopsis



Gary boasts an extensive 38 year-career in the Maintenance and Reliability
field. Beginning as an
apprentice maintenance technician with Imperial Chemical Industries (ICI) UK,
Gary was seconded to
the ICI MT group where he became trained in RCM, RCA and TPM techniques. Gary
left ICI after 15
years and emigrated to New Zealand where he became a site reliability engineer
at Shell Todd Oil
Services. This was followed by five years in Australia working as a Reliability
Consultant in the Mining
and Refining sectors.
In 2009 Gary returned to the UK, were he spent two years with Syngenta as a site
reliability engineer.
Here he implemented the Root Cause Analysis process and used the Isograph AWB
software for
reliability improvement and facilitated studies both in the UK and Switzerland.
In 2018, Gary started his own company Pro-Reliability Solutions, and they now
have offices in the UK,
Ireland, and the Middle East.
Gary has delivered various reliability studies, root cause analysis
investigations, and maintenance and
reliability training courses around the world. These are within numerous
industry verticals such as oil
and gas, pharmaceutical, water, food and beverage, chemical, automotive, and
general manufacturing
companies.





This presentation from Pro-Reliability Solution will look at how water utility
companies are modeling their asset base using well known ‘Reliability’
techniques that will return optimized costs at lowest risk. If your maintenance
budget is out of control or you are experiencing unexpected failures of critical
assets then this presentation will take you through some key steps that focus on
reversing this situation. We will step through the process of how to develop an
optimized strategy for both new designs or existing plant, and discuss some case
studies where others have performed these activities for maximum return.


BARRY WALSH

COUNTRY MANAGER – IRELAND - EUROPEAN ENERGY A/S

Speaker Bio



Barry qualified as a Chemical & Process Engineer from CIT in 1997 and spent the
first 15 years of his career working on bulk pharma and biotech projects from
design to commissioning for a range of multi-national companies. Seeing the
future importance of sustainability, he ‘pivoted’ around 2010 to get involved in
clean tech start-ups, and transitioned fully into the development of Solar PV
with a role in Temporis Capital from 2015. He subsequently moved into a role on
the Investment Management team of the Aurora Fund, a renewable energy
development fund backed by ISIF. In 2022 he moved to the Country Manager role
for EE’s expansion into Ireland and has been progressing wind, solar and
Power-to-X projects from inception through to construction since then.

European Energy A/S (known as EE) is a Danish based renewable energy developer
founded in 2004 and active in over 30 countries worldwide. EE has over 30GW of
project in development across Onshore and Offshore Wind, Solar PV and more
recently in construction of the worlds largest Green Methanol plants
(Power-to-X)


DAMIAN WHITE

CHIEF TECHNOLOGY OFFICER - DATALOGIX

"OT CYBERSECURITY RESILIENCE IN PHARMACEUTICAL MANUFACTURING"

Speaker Bio Synopsis



Damian White CTO @ DataLogiX Damian White is an expert in the field of securing
Operational Technology Networks and is the Chief Technology Officer of
DataLogiX, a leading company specialising in OT cybersecurity for global
organisations. With over 25 years of experience working closely with
multinational pharmaceutical companies, Damian possesses an in-depth
understanding of the unique challenges faced by industries such as life science
manufacturing. His expertise in OT security has been instrumental in
safeguarding the uptime, security, and safety of industrial environments and
critical infrastructure worldwide. DataLogiX's vendor-independent status has
empowered Damian and his team to design, configure, deploy, and support
operational technology networks for major global pharmaceutical companies,
ensuring their operations remain resilient against cyber threats. Known for his
passion for innovation and dedication to delivering unparalleled results,
Damian's leadership at DataLogiX has solidified the company's position as a
trusted partner in the world of OT cybersecurity. His commitment to excellence
and driving transformative solutions has earned him a reputation as a
sought-after thought leader in the industry.





The intersection of IT (Information Technology) and OT has significantly
transformed the landscape of pharmaceutical manufacturing. As Operational
Technology becomes increasingly integrated with digital networks and systems,
the potential attack surface for cyber adversaries expands. A successful
cyberattack on OT systems can lead to devastating consequences, including
production disruptions, compromised product quality, safety hazards, and even
threats to human health. In my talk, I will delve into the key reasons why the
Life Science sector must prioritise cybersecurity for Operational Technology to
build resilience against Cyber Threats. The pharmaceutical manufacturing process
relies heavily on interconnected and automated systems. Implementing robust
cybersecurity measures becomes imperative to safeguard against malicious
attacks, ensuring the uninterrupted production of life-saving medications. In my
presentation, I will also discuss best practices and practical strategies to
enhance OT cybersecurity resilience in pharmaceutical manufacturing. I aim to
highlight real-world case studies and lessons learned from the industry,
empowering the audience with actionable insights to tackle the cybersecurity
challenges they face.




SPONSORS

 
 
 
CONTACT
 * Home
 * Register
 * Contact